The AIR group has two main research areas; to explore new treatment possibilities against the intracellular pathogen Chlamydia spp. and to study bacterial biofilms and search for novel ways to counter them to solve the highly relevant medical problems they cause. We belong to the discipline of Pharmaceutical Biology at the Division of Pharmaceutical Biosciences, Faculty of Pharmacy. We are also part of the Pharmaceutical Design and Discovery group within the faculty’s Drug Research program.